Navellier & Associates Inc. Reduces Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Navellier & Associates Inc. cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 23.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,193 shares of the medical device company’s stock after selling 993 shares during the period. Navellier & Associates Inc.’s holdings in Cooper Companies were worth $352,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. LRI Investments LLC lifted its holdings in Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after buying an additional 112 shares in the last quarter. Mitchell & Pahl Private Wealth LLC lifted its holdings in Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock valued at $881,000 after buying an additional 117 shares in the last quarter. Commonwealth Equity Services LLC lifted its holdings in Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after buying an additional 118 shares in the last quarter. Bleakley Financial Group LLC lifted its holdings in Cooper Companies by 2.1% during the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock valued at $636,000 after buying an additional 119 shares in the last quarter. Finally, First Horizon Advisors Inc. lifted its holdings in Cooper Companies by 4.8% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock valued at $236,000 after buying an additional 125 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 0.9 %

NASDAQ:COO opened at $100.80 on Friday. The company has a market cap of $20.08 billion, a PE ratio of 56.16, a P/E/G ratio of 2.14 and a beta of 0.99. The Cooper Companies, Inc. has a twelve month low of $82.21 and a twelve month high of $112.38. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $105.91 and its two-hundred day moving average is $98.26.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 EPS. Analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insiders Place Their Bets

In other news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. This represents a 24.94 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 256,373 shares of company stock valued at $27,637,427. Insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the subject of a number of research analyst reports. Piper Sandler lifted their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Morgan Stanley boosted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Tuesday, September 10th. Finally, Robert W. Baird boosted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.